2 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
Follow AltaRex: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer oregovomab - Fallopian Tube Cancer, Ovarian Cancer | Phase 2 | Unknown | AltaRex | 102 | 1998-11-01 | 2013-11-06 |
| Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy oregovomab - Fallopian Tube Cancer, Ovarian Cancer | Phase 2 | Unknown | AltaRex | 400 | 1998-04-01 | 2013-11-06 |
Carcinoma, Ovarian Epithelial (2) · Fallopian Tube Neoplasms (2) · Ovarian Neoplasms (2)
oregovomab (2)
Canada (2) · United States (2)
Jonathan S. Berek, MD (1) · Michael A. Bookman, MD (1)